Kim et al., 2001 - Google Patents
Determination of human angiotensin converting enzyme (ACE) gene polymorphisms in erectile dysfunction: frequency differences of ACE gene polymorphisms …Kim et al., 2001
View PDF- Document ID
- 4955415668422018807
- Author
- Kim D
- Choi S
- Lee H
- Park J
- Yi H
- Publication year
External Links
Snippet
DD genotype with various diseases is controversial, due to methodological and technical variations in detection of the polymorphisms. We investigated a possible association between the DD genotype and erectile dysfunction in a Korean population, and compared …
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6846—Common amplification features
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cascorbi et al. | Frequency of single nucleotide polymorphisms in the P‐glycoprotein drug transporter MDR1 gene in white subjects | |
| Soret et al. | Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I | |
| WO2018095401A1 (en) | Improved arms primer structure (super-arms) and usage method therefor | |
| Kim et al. | Determination of human angiotensin converting enzyme (ACE) gene polymorphisms in erectile dysfunction: frequency differences of ACE gene polymorphisms according to the method of analysis | |
| Sachse et al. | Flavin monooxygenase 3 (FMO3) polymorphism in a white population: allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism | |
| Chen et al. | UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis | |
| EP1186672A2 (en) | Polymorphisms in the human organic anion transporter C (OATP-C) gene | |
| JP2010535501A (en) | Methods to identify individuals at risk of thiopurine drug resistance and thiopurine drug intolerance | |
| Takekuma et al. | Contribution of polymorphisms in UDP-glucuronosyltransferase and CYP2D6 to the individual variation in disposition of carvedilol | |
| CN1213406A (en) | Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylasse deficient cells | |
| EP1469084A2 (en) | Polymorphisms in the human KDR gene | |
| WO2007020081B1 (en) | Composition and method for determination of ck19 expression | |
| EP1276752B1 (en) | Method of evaluating a risk of a subject of developing vascular complications | |
| Barbagallo et al. | Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene | |
| Bhavani et al. | Gender specific association of insertion/deletion polymorphism of the human angiotensin converting enzyme gene with essential hypertension | |
| Tabel et al. | Effects of genetic polymorphisms of the renin-angiotensin system in children with nephrotic syndrome | |
| Iqbal et al. | Association study of the angiotensin-converting enzyme (ACE) gene G2350A dimorphism with myocardial infarction | |
| AU4840393A (en) | Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway | |
| Sandoughi et al. | Association of eNOS gene polymorphisms and systemic lupus erythematosus in southeast Iran | |
| JP4169143B2 (en) | Drug metabolism test method and test drug using polymorphism of metabolic enzyme CYP2C8, and compound screening method for improving drug metabolism | |
| JP4121764B2 (en) | Testing method for predisposition to thrombus formation | |
| McCarthy | A Polymerase Chain Reaction Based Method for the Detection of Low Abundance Mutations | |
| WO2022182985A1 (en) | Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (gpam) inhibitors | |
| Crackower et al. | P-144: ACE2-a novel candidate gene for hypertension | |
| JP2006141314A (en) | Primer set and probe for detecting polymorphism of CYP2C8 gene, test agent for metabolic activity of the enzyme, and test method thereof |